Live and On-Demand Activities

Filter Activities

Clear

A New Treatment Era for Light-Chain Amyloidosis:Interprofessional Lessons From a Center of Excellence

1.00 hr(s) | ABIM , CME , CPE , MOC , NCPD

Therapeutic Area(s): Cardiology , Hematology, Benign , Oncology

Release Date: July 9, 2021

Expiration Date: July 8, 2022

Location: Internet Activity Enduring

In this activity, a panel of experts discusses a team-based approach to the management of light chain (AL) amyloidosis. Hear from Suzanne Lentzsch, MD, PhD, Mathew S. Maurer, MD, and Margaret Cuomo, MSN, FNP-C, from the Columbia University Medical Center, as they give insights on diagnostic strategies for AL amyloidosis and as they explore treatment guidelines, evidence, and safety concerns of established and novel approaches to managing AL amyloidosis.

Teaming Up to Overcome Challenges in the Diagnosis and Management of Noninfectious Uveitis: Enhancing Multidisciplinary Care in the Biologic Therapy Era

1.00 hr(s) | ABO , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: Noninfectious Uveitis

Therapeutic Area(s): Rheumatology

Release Date: June 28, 2021

Expiration Date: June 27, 2022

Location: Internet Activity Enduring

In this activity, experts in ophthalmology and rheumatology discuss challenges in the diagnosis and management of noninfectious uveitis.

Emerging Therapies and Management Strategies of MDS and Myeloid Malignancies for Nurse Practitioners

1.5 hr(s) | Nurse Practitioners

Specialty: MDS , Myelodysplastic Syndromes

Therapeutic Area(s): Hematology, Benign , Oncology

Release Date: November 9, 2020

Expiration Date: November 8, 2021

Location: Internet Activity Enduring Material

This program was recorded at the ONS Bridger on September 17, 2020 and is targeted to clinical nursing professionals in oncology. Case studies were used to illustrate treatment decision-making and therapeutic challenges.

Emerging Therapies and Management Strategies of MDS and Myeloid Malignancies for Nurses

1.5 hr(s) | NCPD

Specialty: MDS , Myelodysplastic Syndromes

Therapeutic Area(s): Hematology, Benign , Oncology

Release Date: November 9, 2020

Expiration Date: November 8, 2021

Location: Internet Activity Enduring Material

This program was recorded at the ONS Bridger on September 17, 2020 and is targeted to clinical nursing professionals in oncology. Case studies were used to illustrate treatment decision-making and therapeutic challenges.

Genomics and Hematologic Malignancies: Beyond the Philadelphia Chromosome

1.5 hr(s) | NCPD , Nurse Practitioners , Social Worker

Therapeutic Area(s): Genomics

Release Date: June 24, 2021

Expiration Date: June 30, 2021

Location: Internet Activity Enduring Material

It has been 60 years since the discovery of a chromosomal abnormality in CML; the so-called Philadelphia chromosome. Since then genomics has revolutionized cancer care and the impact in hematologic malignancies is plentiful. Healthcare providers must understand the science to be able to apply in practice and communicate complex information to patients and caregivers. This session will provide an overview of foundational genomic concepts and how genomics is applied across the care continuum for hematologic cancers. Case studies examining the application of testing to “real life” situations will be presented and resources for patients will be shared.

The Spectrum of MDS: Disease Management and Patient Education

1.5 hr(s) | NCPD , Nurse Practitioners

Specialty: Myelodysplastic Syndromes

Therapeutic Area(s): Hematology, Benign , Oncology

Release Date: June 15, 2021

Expiration Date: June 14, 2022

Location: Internet Activity Enduring Material

The symposium was presented at the ONS Annual Congress virtual platform on April 29, 2021 and targeted to inpatient and outpatient clinical nursing professionals in oncology. Topics will include the latest developments in diagnosing and treating myeloid malignancies; current and emerging treatment options for low-risk MDS, high-risk MDS, and secondary AML; clinical trial participation; disease management for chronic anemia, side effects and treatment adherence; psychosocial considerations and palliative care to improve the quality of life for this patient population. Case studies will be used to illustrate treatment decision-making and therapeutic challenges.

Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option

1.00 hr(s) | CME

Specialty: Psoriasis

Therapeutic Area(s): Dermatology

Release Date: June 21, 2021

Expiration Date: June 20, 2022

Location: Internet Activity Enduring

In this activity, an expert in dermatology discusses unmet needs of patients with moderate to severe psoriasis and the clinical potential of targeting the TYK2 pathway as a novel nonbiologic oral therapeutic option.

New and Emerging Therapeutic Strategies in Bladder Cancer: Updates in Early-Stage Disease and Beyond

0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: Bladder Cancer

Therapeutic Area(s): Oncology , Urologic oncology

Release Date: June 23, 2021

Expiration Date: June 22, 2022

Location: Internet Activity Enduring

In this activity, an expert in genitourinary oncology discusses new and emerging strategies for the management of patients with bladder cancer.

1 2 3 4 14
Copy link
Powered by Social Snap